Serum Institute seeks full market authorisation for Covishield vaccine
Adar Poonawalla, chief executive officer, SII, tweeted on Friday and said the company had supplied 1.25 billion doses of Covishield in India and the government had enough data for this permission. Serum Institute of India (SII) has sought full approval for its Covid-19 vaccine, Covishield. SII has applied to the ministry of health and family … Read more